HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wilson, J. F. Articles by Rausch, R. L. Search for Related Content PubMed PubMed Citation Articles by Wilson, J. F. Articles by Rausch, R. L.

Alveolar Hydatid Disease

A Review of Clinical Features of 33 Indigenous Cases of Echinococcus Multilocularis Infection in Alaskan Eskimos^*

J. F. Wilson AND R. L. Rausch

The clinical features of 33 cases of alveolar hydatid disease (AHD) in Alaskan Eskimos and a review of the surgical experience with this disease are presented. Among untreated patients, progression of the disease to a fatal outcome was observed in 70%. The primary hepatic lesion resembles cancer, and errors in diagnosis by both the surgeon and pathologist are common. Although surgical resection of the entire primary hepatic lesion offers the only proven curative treatment, only 26% of those explored were resectable. All seven patients resected for cure are alive 6–27 years post-operatively (average survival, 14.7 years). A 5-year experience with continuous mebendazole therapy in the management of five nonresectable cases of AHD indicates that a favorable effect of this drug is being observed. It now appears that Echinococcus infections are no longer the sole province of the surgeon. Although the role of medical therapy is not yet clearly defined, it must be considered in the management of all cases of AHD. The first reported locally-acquired case of AHD in the conterminous United States, and the widespread occurrence and expanding range of E. multilocularis in the north-central United States and south-central Canada, point to the increasing public health importance of alveolar hydatid disease.

Accepted for publication May 31, 1980.

^* This study was supported in part by Grant 79-I/78-Gr from the Indian Health Service, U.S. Public Health Service, and Grant AI-15172 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, U.S. Public Health Service.

Present address: Division of Animal Medicine, School of Medicine, University of Washington, Seattle, Washington 98195.

This article has been cited by other articles:

				A. Lowichik and A. J. Ruff Topical Review: Parasitic Infections of the Central Nervous System in Children. Part III: Space-Occupying Lesions J Child Neurol, May 1, 1995; 10(3): 177 - 190. [Abstract] [PDF]

				D. F. Williams, G. A. Williams, J. G. Caya, R. P. Werner, and T. J. Harrison Intraocular Echinococcus multilocularis Arch Ophthalmol, August 1, 1987; 105(8): 1106 - 1109. [Abstract] [PDF]

				P. M. Schantz Effective Medical Treatment for Hydatid Disease? JAMA, April 12, 1985; 253(14): 2095 - 2097. [Abstract] [PDF]